Speed is the essence: According to Mike Mencer, Patheon, there needs to be consistent focus on innovative solutions that improve speed to market, not only for vaccines, but for new drugs and drug-device combinations
CDMO Recipharm has appointed Jean-François Hilaire to the new position of chief strategy officer, joining Recipharm’s group management team.
Hilaire is a pharmacist and graduated from the university of Bordeaux and alumni of the CEDEP General Manager Program (campus INSEAD – Fontainebleau). He brings a broad experience base acquired in commercial as well as in manufacturing and supply leadership roles at Fournier, Solvay and Abbott.
Commenting on the appointment, CEO Thomas Eldered said: “Jean- François Hilaire will bring valuable and relevant experience from the pharmaceutical industry in general but also very important views from outsourcing of pharmaceutical development and manufacturing.”
Hilaire said: “I am glad to be joining Recipharm and its leadership team whom I have had the chance to know for several years and admire their entrepreneurship. Furthermore, with the current transformation of the pharmaceutical industry, I see Recipharm as very well positioned to catch sizable business opportunities in extending the value created for its customers."